C1qR(P), the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1929-1935

  Nepomuceno, Ronald R ^a,b   Tenner, Andrea J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; C1QBP PROTEIN, HUMAN; CARRIER PROTEIN; COMPLEMENT 1Q RECEPTOR; HERMES ANTIGEN; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN;

ARTICLE; BONE MARROW CELL; COMPLEMENT SYSTEM; DNA PROBE; ENDOTHELIUM CELL; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NORTHERN BLOTTING; PHAGOCYTOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE; BIOSYNTHESIS; BLOOD; CELL CULTURE; CELL MEMBRANE; CELL STRAIN HL 60; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MONOCYTE; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANTIGENS, CD44; BLOOD PLATELETS; BLOTTING, NORTHERN; CARRIER PROTEINS; CELL MEMBRANE; COMPLEMENT C1Q; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIAL PROTEINS; MONOCYTES; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; RECEPTORS, COMPLEMENT; TUMOR CELLS, CULTURED;

EID: 0032519011     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Rogers, J., N. R. Cooper, S. Webster, J. Schultz, P. L. McGeer, S. D. Styren, W. H. Civin, L. Brachova, B. Bradt, P. Ward, and I. Lieberburg. 1992. Complement activation by beta-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. 89:10016.
2. Jiang, H., D. Burdick, C. G. Glabe, C. W. Cotman, and A. J. Tenner. 1994. β-amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152:5050.
3. Cooper, N. R. 1985. The classical complement pathway: activation and regulation of the first complement component. Adv. Immunol. 37:151.
4. Bobak, D. A., M. M. Frank, and A. J. Tenner. 1986. Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and FMLP. J. Immunol. 136:4604.
5. Young, K. R., J. L. Ambrus, Jr., A. Malbran, A. S. Fauci, and A. J. Tenner. 1991. Complement subcomponent C1q stimulates immunoglobulin production by human B lymphocytes. J. Immunol. 146:3356.
6. Hamada, A., and B. M. Greene. 1987. C1q enhancement of IgG-dependent eosinophil-mediated killing of schistosomula in vitro. J. Immunol. 138:1240.
7. Andrews, B. S., M. Shadforth, P. Cunningham, and J. S. Davis IV. 1981. Demonstration of a C1q receptor on the surface of human endothelial cells. J. Immunol. 127:1075.
8. Zhang, S. C., D. R. Schultz, and U. S. Ryan. 1986. Receptor-mediated binding of C1q on pulmonary endothelial cells. Tissue Cell 18:13.
9. Daha, M. R., A. M. M. Miltenburg, P. S. Hiemstra, N. Klar-Mohamad, L. A. Van Es, and V. W. M. Van Hinsbergh. 1988. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro. Eur. J. Immunol. 18:783.
10. Peerschke, E. I. B., and B. Ghebrehiwet. 1987. Human blood platelets possess specific binding sites for C1q. J. Immunol. 138:1537.
11. Bordin, S., M. Smith, B. Ghebrehiwet, D. Oda, and R. C. Page. 1992. Smooth muscle and epithelial cells express specific binding sites for the C1q component of complement. Clin. Immunol. Immunopathol. 63:51.
12. Bordin, S., W. P. Kolb, and R. C. Page. 1983. C1q Receptors on cultured human gingival fibroblasts: analysis of binding properties. J. Immunol. 130:1871.
13. Tenner, A. J. 1993. Functional aspects of the C1q receptors. Behring Inst. Mitt. 93:241.
14. Bobak, D. A., M. M. Frank, and A. J. Tenner. 1988. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes. Eur. J. Immunol. 18:2001.
15. Bobak, D. A., T. G. Gaither, M. M. Frank, and A. J. Tenner. 1987. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J. Immunol. 138:1150.
16. Ohkuro, M., K. Kobayashi, K. Takahashi, and S. Nagasawa. 1994. Effect of C1q on the processing of immune complexes by human neutrophils. Immunology 83:507.
17. Tenner, A. J., and N. R. Cooper. 1982. Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component. J. Immunol. 128:2547.
18. Shingu, M., K. Yoshioka, M. Nobunaga, and T. Motomatu. 1989. C1q binding to human vascular smooth muscle cells mediates immune complex deposition and superoxide generation. Inflammation 13:5:561.
19. Hamada, A., J. Young, R. A. Chmielewski, and B. M. Greene. 1988. C1q enhancement of antibody-dependent granulocyte mediated killing of nonphagocytosable targets in vitro. J. Clin. Invest. 82:945.
20. Ryan, U. S., D. R. Schultz, J. D. Goodwin, J. M. Vann, M. P. Selvaraj, and M. A. Hart. 1989. Role of C1q in phagocytosis of Salmonella minnesota by pulmonary endothelial cells. Infect. Immun. 57:1356.
21. 2+ in mouse fibroblasts. J. Immunol. 141:3177.
22. Rimoldi, M. T., A. J. Tenner, D. A. Bobak, and K. A. Joiner. 1989. Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes. J. Clin. Invest. 84:1982.
23. Daha, M. R., N. Klar, R. Hoekzema, and L. A. Van Es. 1990. Enhanced Ig production by human peripheral lymphocytes induced by aggregated C1q. J. Immunol. 144:1227.
24. Guan, E., W. H. Burgess, S. L. Robinson, E. B. Goodman, K. J. McTigue, and A. J. Tenner. 1991. Phagocytic cell molecules that bind the collagen-like region of C1q: involvement in the C1q-mediated enhancement of phagocytosis. J. Biol. Chem. 266:20345.
25. p, the human C1q/ MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6:119.
26. Guan, E., S. L. Robinson, E. B. Goodman, and A. J. Tenner. 1994. Cell surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis. J. Immunol. 152:4005.
27. Lozada, C., R. I. Levin, M. Huie, R. Hirschhorn, D. Naime, M. Whitlow, P. A. Recht, B. Golden, and B. N. Cronstein. 1995. Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc. Natl. Acad. Sci. USA 92:8378.
28. r component of the C1q receptor. Immunity 3:485.
29. Tenner, A. J., S. L. Robinson, J. Borchelt, and J. R. Wright. 1989. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR-and CR1-mediated phagocytosis. J. Biol. Chem. 264:13923.
30. Goodman, E. B., and A. J. Tenner. 1992. Signal transduction mechanisms of C1q-mediated superoxide production: evidence for the involvement of temporally distinct stauosporine insensitive and sensitive pathways. J. Immunol. 148:3920.
31. Wener, M. H., S. Uwatoko, and M. Mannik. 1989. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum. 32:544.
32. Brunswick, M., C. H. June, F. D. Finkelman, and J. J. Mond. 1989. Different patterns of inositol polyphosphate production are seen in B lymphocytes after cross-linking of sIg by anti-Ig antibody or by a multivalent anti-Ig antibody dextran conjugate. J. Immunol. 143:1414.
33. Harlow, E., and D. Lane. 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, p. 298.
34. Lionetti, F. J., S. M. Hunt, and C. R. Valeri. 1980. Methods of Cell Separation. Plenum Publishing Corp., New York, p. 141.
35. Sambrook, J., E. F. Fritsch, and F. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. 2nd Ed., Cold Spring Harbor Press, Plainview, New York. p. 12.1.
36. Bordin, S., W. P. Kolb, and R. C. Page. 1983. C1q receptors on cultured human gingival fibroblasts: analysis of binding properties. J. Immunol. 130:1871.
37. Luddington, S., E. E. Qwarnström, R. C. Page, and S. Bordin. 1993. Expression and function of gingival fibroblast C1q receptors are upregulated by interleukin-1β and transforming growth factor-β. J. Cell. Physiol. 155:157.
38. Collins, S. J., R. C. Gallo, and R. E. Gallagher. 1977. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270:347.
39. James, S. Y., M. A. Williams, S. M. Kelsey, A. C. Newland, and K. W. Colston. 1997. Interaction of vitamin D derivatives and granulocyte-macrophage colony-stimulating factor in leukaemic cell differentiation. Leukemia 11:1017.
40. Fleit, H. B., S. D. Wright, C. J. Durie, J. E. Valinsky, and J. C. Unkeless. 1984. Ontogeny of Fc receptors and complement receptor (CR3) during human myeloid differentiation. J. Clin. Invest. 73:516.
41. Thomas, R., L. S. Davis, and P. E. Lipsky. 1993. Isolation and characterization of human peripheral blood dendritic cells. J. Immunol. 150:821.
42. Chiang, T. M., R. C. Gupta, and A. H. Kang. 1985. Effect of the C1q on the soluble collagen-platelet interaction. Thromb. Res. 37:605.
43. Suba, E. A., and G. Csako. 1976. C1q(C1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules. J. Immunol. 117:304.
44. 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity. J. Exp. Med. 178:579.
45. Jentoft, N. 1990. Why are proteins O-glycosylated? Trends Biochem. Sci. 15:291.
46. Malhotra, R., A. C. Willis, J. C. Jensenius, J. Jackson, and R. B. Sim. 1993. Structure and homology of human C1q receptor (collectin receptor). Immunology 78:341.
47. Dedhar, S. 1994. Novel functions for calreticulin: interaction with integrins and modulation of gene expression. Trends Biochem. Sci. 19:269.
48. Wada, I., S. Imai, M. Kai, F. Sakane, and H. Kanoh. 1995. Chaperone function of calreticulin when expressed in the endoplasmic reticulum as the membrane-anchored and soluble forms. J. Biol. Chem. 270:20298.
49. Ghebrehiwet, B., L. Silvestri, and C. McDevitt. 1984. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q purification and immunochemical characterization. J. Exp. Med. 160:1375.
50. Ghebrehiwet, B., S. Bossone, A. Erdei, and K. B. M. Reid. 1988. Reversible biotinylation of C1q with a cleavable biotinyl derivative: application in C1q receptor (C1qR) purification. J. Immunol. Methods 110:251.
51. Malhotra R., and R. B. Sim. 1989. Chemical and hydrodynamic characterization of the human leucocyte receptor for complement subcomponent C1q. Biochem. J. 262:625.
52. Chen, A., S. Gaddipati, Y. Hong, D. J. Volkman, E. I. B. Peerschke, and B. Ghebrehiwet. 1994. Human T cells express specific binding sites for C1q: role in T cell activation and proliferation. J. Immunol. 153:1430.
53. D'Cruz, O. J., C. A. Toth, and G. G. Haas, Jr. 1996. Recombinant soluble human complement receptor type 1 inhibits antisperm antibody-and neutrophil-mediated injury to human sperm. Biol. Reprod. 54:1217.
54. Ghebrehiwet, B., R. R. Kew, B. L. Gruber, M. J. Marchese, E. I. B. Peerschke, and K. B. M. Reid. 1995. Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis. J. Immunol. 155:2614.
55. Peerschke, E. I. B., R. Malhotra, B. Ghebrehiwet, K. B. M. Reid, A. C. Willis, and R. B. Sim. 1993. Isolation of a human endothelial cell C1q receptor (C1qR). J. Leukocyte Biol. 53:179.
56. Bordin, S., B. Ghebrehiwet, and R. C. Page. 1990. Participation of C1q and its receptor in adherence of human diploid fibroblast. J. Immunol. 145:2520.
57. Esparza, B., H. Sánchez, M. Ruiz, M. Barranquero, E. Sabino, and F. Merino. 1996. Neutrophil function in elderly persons assessed by flow cytometry. Immunol. Invest. 25:185.
58. Ghebrehiwet, B., B. Lim, E. I. B. Peerschke, A. C. Willis, and K. B. M. Reid. 1994. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J. Exp. Med. 179:1809.
59. Peerschke, E. I. B., K. B. M. Reid, and B. Ghebrehiwet. 1994. Identification of a novel 33-kDa C1q-binding site on human blood platelets. J. Immunol. 152: 5896.
60. Eggleton, P., B. Ghebrehiwet, K. N. Sastry, J. P. Coburn, K. S. Zaner, K. B. M. Reid, and A. I. Tauber. 1995. Identification of gC1q-binding protein (gC1q-R) on !he surface of human neutrophils: subcellular localization and binding properties in comparison with the cC1q-R. J. Clin. Invest. 95:1569.
61. van den Berg, R. H., F. Prins, M. C. Faber-Krol, N. J. Lynch, W. Schwaeble, L. A. Van Es, and M. R. Daha. 1997. Intracellular localization of the human receptor for the globular domains of C1q. J. Immunol. 158:3909.
62. Herwald, H., J. Dedio, R. Kellner, M. Loos, and W. Müller-Esterl. 1996. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells: identity with the gC1q receptor. J. Biol. Chem. 271:13040.
63. Dedio, J., and W. Muller-Esterl. 1996. Kininogen binding protein p33/gC1qR is localized in the vesicular fraction of endothelial cells. FEBS Lett. 399:255.
64. Lim, B. L., K. B. M. Reid, B. Ghebrehiwet, E. I. B. Peerschke, L. A. E. Leigh, and K. T. Preissner. 1996. The binding protein for globular heads of complement C1q, gC1qR. J. Biol. Chem. 271:26739.
65. Daha, M. R., L. Dunn, R. van den Berg, Y. Muizert-de Lange, A. Garritson, and L. A. Van Es. 1993. Isolation and function of a human endothelial cell C1q receptor. Mediat. Inflamm. 2:447.
66. van den Berg, R. H., M. Faber-Krol, L. A. Van Es, and M. R. Daha. 1995. Regulation of the function of the first component of complement by human C1q receptor. Eur. J. Immunol. 25:2206.
67. Capsoni, F., F. Minonzio, A. M. Ongari, V. Carbonelli, A. Galli, and C. Zanussi. 1995. IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-gamma. J. Leukocyte Biol. 58:351.
68. Collins, H. L., and G. J. Bancroft. 1992. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22:1447.
69. Brown, E. J. 1986. The role of extracellular matrix proteins in the control of phagocytosis. J. Leukocyte Biol. 39:579.
70. Kitagawa, S., A. Yuo, M. Yagisawa, E. Azuma, M. Yoshida, Y. Furukawa, M. Takahashi, J. Masuyama, and F. Takaku. 1996. Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release. Exp. Hematol. 24:559.
71. Vesanen, M., M. Wessman, M. Salminen, and A. Vaheri. 1992. Activation of integrated human immunodeficiency virus type 1 in human neuroblastoma cells by the cytokines tumour necrosis factor alpha and interleukin-6. J. Gen. Virol. 73:1753.
72. McIntosh, J. C., S. Mervin-Blake, E. Conner, and J. R. Wright. 1996. Surfactant protein-A protects growing cells and reduces tumor necrosis factor-α activity from lipopolysaccharide-stimulated macrophages. Am. J. Physiol. 271:L310.